June 8, 2018 Voluntary Nationwide Recall for Two Lots of Naloxone Hydrochloride Injection due to the Potential Presence of Particulate Matter The Food and Drug Administration (FDA) is urging Naloxone carriers to check their product against a national recall list.  The maker of the drug, Hospira, has issued a voluntary recall of the opioid overdose reversal drug Naloxone due to the potential presence of embedded and loose particulate matter in the syringe plunger. Please inform healthcare professionals in your network immediately.  The FDA includes information on the specific product lot numbers affected by this recall. NAADAC, The Association for Addiction Professionals 44 Canal Center Plaza, Suite 301, Alexandria, VA 22314 Phone: 703.741.7686 / 800.548.0497 Send to Friend |  | Subscribe |